全文获取类型
收费全文 | 3271篇 |
免费 | 176篇 |
国内免费 | 32篇 |
专业分类
耳鼻咽喉 | 32篇 |
儿科学 | 39篇 |
妇产科学 | 23篇 |
基础医学 | 438篇 |
口腔科学 | 39篇 |
临床医学 | 241篇 |
内科学 | 654篇 |
皮肤病学 | 55篇 |
神经病学 | 565篇 |
特种医学 | 171篇 |
外科学 | 586篇 |
综合类 | 23篇 |
预防医学 | 132篇 |
眼科学 | 107篇 |
药学 | 220篇 |
中国医学 | 10篇 |
肿瘤学 | 144篇 |
出版年
2023年 | 17篇 |
2022年 | 25篇 |
2021年 | 65篇 |
2020年 | 53篇 |
2019年 | 60篇 |
2018年 | 70篇 |
2017年 | 50篇 |
2016年 | 81篇 |
2015年 | 92篇 |
2014年 | 128篇 |
2013年 | 169篇 |
2012年 | 228篇 |
2011年 | 235篇 |
2010年 | 139篇 |
2009年 | 139篇 |
2008年 | 204篇 |
2007年 | 243篇 |
2006年 | 210篇 |
2005年 | 224篇 |
2004年 | 192篇 |
2003年 | 183篇 |
2002年 | 182篇 |
2001年 | 46篇 |
2000年 | 33篇 |
1999年 | 30篇 |
1998年 | 39篇 |
1997年 | 35篇 |
1996年 | 26篇 |
1995年 | 25篇 |
1994年 | 21篇 |
1993年 | 14篇 |
1992年 | 10篇 |
1991年 | 11篇 |
1990年 | 6篇 |
1989年 | 11篇 |
1988年 | 14篇 |
1987年 | 12篇 |
1986年 | 6篇 |
1985年 | 10篇 |
1984年 | 8篇 |
1983年 | 8篇 |
1982年 | 9篇 |
1981年 | 12篇 |
1980年 | 4篇 |
1978年 | 5篇 |
1976年 | 5篇 |
1960年 | 4篇 |
1938年 | 4篇 |
1925年 | 5篇 |
1921年 | 4篇 |
排序方式: 共有3479条查询结果,搜索用时 15 毫秒
1.
Attar Armin Azizi Fatemeh Abtahi Firoozeh Karimi Mojtaba 《The international journal of cardiovascular imaging》2022,38(5):1021-1028
The International Journal of Cardiovascular Imaging - Anthracycline agents are routinely used for treatment of many types of malignancy, while imposing the risk for cardiotoxicity (AT-CMP).... 相似文献
2.
Azarshahri Armin Rainchuso Lori Vineyard Jared Giblin-Scanlon Lori 《Maternal and child health journal》2022,26(6):1339-1349
Maternal and Child Health Journal - The purpose of this study was to assess oral health knowledge, attitudes, and practices of women who had given birth in the United States within the past 2... 相似文献
3.
Weidner Kathrin Behnes Michael Schupp Tobias Hoppner Jorge Ansari Uzair Mueller Julian Lindner Simon Borggrefe Martin Kim Seung-hyun Huseyinov Aydin Ellguth Dominik Akin Muharrem Meininghaus Dirk Große Bertsch Thomas Taton Gabriel Bollow Armin Reichelt Thomas Engelke Niko Reiser Linda Akin Ibrahim 《Journal of interventional cardiac electrophysiology》2022,63(1):13-20
Journal of Interventional Cardiac Electrophysiology - The study sought to assess the prognostic impact of chronic kidney disease (CKD) in patients with electrical storm (ES). ES represents a... 相似文献
4.
5.
Robert Zeiser Dietrich W. Beelen Wolfgang Bethge Martin Bornhäuser Gesine Bug Andreas Burchert Maximilian Christopeit Justus Duyster Jürgen Finke Armin Gerbitz Jan Henning Klusmann Guido Kobbe Michael Lübbert Carsten Müller-Tidow Uwe Platzbecker Wolf Rösler Martin Sauer Christoph Schmid Lutz P. Müller 《Biology of blood and marrow transplantation》2019,25(4):e128-e140
The curative potential of allogeneic hematopoietic cell transplantation (allo-HCT) in the treatment of acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS) relies mainly on the graft-versus-leukemia effect. Relapse after allo-HCT occurs in a considerable proportion of patients and has a dismal prognosis, with still very limited curative potential. This review provides an overview of the established and evolving approaches to preventing or treating relapse of AML and MDS after allo-HCT, in the context of novel insight into the biology of relapse. Established prophylactic measures to prevent relapse include optimized conditioning and graft-versus-host disease (GVHD) prophylaxis, as well as donor lymphocyte infusion (DLI) for high-risk patients; novel immunomodulatory interventions and maintenance approaches are still experimental. Improved diagnostics can detect persistent or recurring disease at a molecular level, enabling early preemptive interventions. Established options include hypomethylating agents and DLI. Standard treatments for hematologic relapse include chemotherapy, cessation of immunosuppressive treatment, and DLI. Experimental approaches include molecular targeted therapies, novel immunomodulatory treatments, and second allo-HCT. For all interventions, the potential risks, including occurrence of GVHD, must be weighed against the benefits individually in each patient. Concurrently, prevention and treatment of relapse after allo-HCT remain challenging and unmet medical needs. 相似文献
6.
Shernan G. Holtan Lin Zhang Todd E. DeFor Nelli Bejanyan Mukta Arora Armin Rashidi Aleksandr Lazaryan Florence Kotiso Bruce R. Blazar John E. Wagner Claudio G. Brunstein Margaret L. MacMillan Daniel J. Weisdorf 《Biology of blood and marrow transplantation》2019,25(9):1884-1889
Graft-versus-host disease (GVHD)-free, relapse-free survival (GRFS) represents complete, ideal recovery after allogeneic hematopoietic cell transplantation (HCT). However, as originally proposed, this composite endpoint does not account for the possibility that HCT complications may improve after treatment. To more accurately estimate survival with response to GVHD and relapse after HCT, we developed a dynamic multistate GRFS (dGRFS) model with outcomes data from 949 patients undergoing their first allogeneic HCT for hematologic malignancy at the University of Minnesota. Because some patients were successfully treated for GVHD and relapse, dGRFS was higher than the originally defined time-to-event GRFS at 1 year (37.0 versus 27.6%) through 4 years (37.4% versus 22.2%). Mean survival without failure events was .52 years (95% confidence interval, .45 to .58 year) greater in dGRFS compared with the originally defined GRFS. Patient age (P< .001), disease risk (P < .001), conditioning intensity (P = .007), and donor type (P = .003) all significantly influenced dGRFS. The multistate model of dGRFS closely estimates the continuing and prevalent severe morbidity and mortality of allogeneic HCT. To serve the greater HCT community in more accurately modeling recovery from transplantation, we provide our R code for determination of dGRFS with annotations in Supplementary Materials. 相似文献
7.
8.
9.
Ingo Borggraefe Moritz Tacke Lucia Gerstl Steffen Leiz Roland Coras Ingmar Blümcke Armin Giese Birgit Ertl‐Wagner Christian T. Thiel Soheyl Noachtar Aurelia Peraud 《Epileptic Disord》2019,21(1):122-127
Focal cortical dysplasia is a common cause of medically refractory epilepsy in infancy and childhood. We report a neonate with seizures occurring within the first day of life. Continuous video‐EEG monitoring led to detection of left motor seizures and a right frontal EEG seizure pattern. Brain MRI revealed a lesion within the right frontal lobe without contrast enhancement. The patient was referred for epilepsy surgery due to drug resistance to vitamin B6 and four antiepileptic drugs. Lesionectomy was performed at the age of two and a half months, and histopathological evaluation confirmed the diagnosis of focal cortical dysplasia type IIb (FCD IIb). The patient is free of unprovoked seizures without medication (Engel Class I) and is normally developed at 36 months after surgery. The case study demonstrates that FCD IIb may cause seizures within the first day of life and that epilepsy surgery can be successfully performed in medically intractable patients with a clearly identifiable seizure onset zone within the first three months of life. Although radical surgery such as hemispherectomy and multi‐lobar resections are over‐represented in early infancy, this case also illustrates a favourable outcome with a more limited resection in this age group. 相似文献
10.